Sinovac (Dalian) Vaccine Technology Co., LTD
Sinovac (Dalian) Vaccine Technology Co., LTD
-- Escort lives and deliver health
Sinovac (Dalian) Vaccine Technology Co., LTD. (hereinafter referred to as "Dalian Sinovac") is a biotechnology high-tech enterprise jointly established by Sinovac Holdings (Hong Kong) Co., LTD and Dalian Kingport Group Co., LTD. Founded in 2010 with registered capital of 348 million YUAN, the company is located in DD Port Industrial Park，Dalian Economic and Technological Development Area. It covers an area of 95,000 square meters, including 52,168 square meters building area. Adhering to the mission of "providing vaccines for the elimination of human diseases", the company is committed to the research, development, production and sales of human vaccines and related products to provide services for the prevention and control of human diseases with the goal of "enabling Chinese children to use world-class vaccines and enabling the world's children to use Vaccines produced in China". Existing staff 531 people, listed products for mumps live attenuated vaccine, live attenuated chicken pox vaccine.
Sinovac's main products are live attenuated mumps vaccine and live attenuated varicella vaccine. Currently, Sinovac has undertaken the production of inactivated COVID-19 vaccine. The company carries the concept that the quality of vaccines comes from the design. The live attenuated mumps vaccines strictly follow the standards of
After ten years of research and development, Sinovac live attenuated varicella vaccine is cultured with SV-1 cell line with independent intellectual property rights of Sinovac. The first virus harvesting process at home and abroad has broken through the bottleneck of similar products' production capacity and improved product industrialization capacity. At the same time, gelatin-free and blood albumin formulation is adopted to reduce the side reaction rate and the risk of exogenous blood contamination in the inoculation process, which has formed a unique core competitiveness of the industry among similar products. The data from the relevant phase iii clinical study fill in the blank of relevant research data in China and provide scientific data basis for disease prevention. Live attenuated varicella vaccine was registered on 18 December 2019 (Approval Number: S20190044), became the first approved production of vaccine in China since the formal implementation of the Vaccine Management Law of the People's Republic of China, and successfully realized the product on the market in April 2020. Currently, we are promoting the WHO pre-certification, and will further provide safe and high-quality vaccine products for domestic and foreign varicella prevention in the future.
Dalian Sinovac is an independent research and development of biological vaccine production enterprises, taking "drive platform by project construction to platform carry more project industrialization" development strategy, the overall layout, hierarchical propulsion, the key breakthrough, form the enterprise as the research subject, with foreign technical cooperation and combination of research and development mode. Through the joint efforts of multiple platforms, live attenuated mumps and varicella vaccines have been developed and marketed, the pre-clinical study of rubella live attenuated vaccine is completed and has obtained the approval for clinical trial; Oral live rotavirus vaccine, live attenuated herpes zoster vaccine, live attenuated MMR vaccine, MMR varicella quadruple vaccine, etc. are undergoing preclinical studies as planned. Sinovac is the first manufacturer in the world to use the human diploid cell line SV-1, which Sinovac holds its own intellectual property rights, for the development and industrial production of human vaccine system. The core technology of live attenuated varicella vaccine holds many independent intellectual property rights; Relevant research results have been published in internationally renowned journals.
In 2021, according to the global epidemic situation, Sinovac Life Sciences Co., Ltd. entrust Dalian Sinovac set up 4 new production line including 2 assembly line with capacity of 100 million doses and 2 packaging line with capacity of 100 million doses in compliance with relevant national regulations to undertake sub-packaging capacity of 200 million doses of COVID-19 vaccine. With the full coordination and resources of the Liaoning Provincial Medical Products Administration and the project teams of Dalian municipal governments at all levels, Sinovac has reached an annual production capacity of 200 million doses, making its contribution to the fight against COVID-19.
In the future, Dalian Sinovac will remain committed to R&D and production of innovative vaccine for human use, gradually become a leading biological pharmaceutical company in Dalian and northeast regional in the field of vaccine for human use, practice the core concept of the enterprise "escort life, deliver health", to promote science technology innovation of the vaccine industry, bring in and train more innovative talents; build Sinovac Vaccine Industrialization Base into an important human vaccine research and industrialization base for sustainable development in Dalian and establish a century-old enterprise with sustainable development. In addition, the company makes its own contributes to improve the prevention and control level of infectious diseases in the region and even at home and abroad, and bear the responsibility of a vaccine enterprise for the country and society.
Dalian Jingang Group Real Estate Development Co., Ltd.
Established in 1993, Dalian Jingang Group Real Estate Development Co., Ltd. has successively developed Gaochengshan, Bay Villa, Gaochengshan market and many other real estate projects in Dalian Development Area with total construction area of more than 800,000 square meters. The company adheres to the concept of "develop one area, benefit one city". All projects completed with standard rate of 100%, and approved by the government and the market.
Dalian Jingang Energy Saving Technology Development Co. Ltd.
Dalian Jingang Energy Saving Technology Development Co. Ltd. is established on May 20, 2019. It is a technology company specialized in energy-saving products such as Gas radiant heating equipment.
Dalian Jingang Industrial Park Co., Ltd
Dalian Jingang Industrial Park Co., Ltd. was established on May 18, 2021 with a registered capital of 50 million US dollars. It is jointly invested by Dalian Jingang Group Co., Ltd. and Hong Kong Xujin Holding Co., Ltd.
Jingang Industrial Park
As the leading company in Dalian industrial real estate industry, Jingang Industrial Park is a comprehensive and intelligent industrial park that provides workshop, dormitory, supporting facilities and services for small and medium-sized enterprises in the field of high-tech products, mold processing, precision electronics, garment processing, machinery and machinery parts assembly.
Dalian Jingang Agriculture Co., Ltd
Dalian Jingang Agriculture Co., LTD., a subsidiary of Dalian Jingang Group Co., LTD., was established in 2013. It is a trading company dedicated to the sales of pesticides, agricultural fertilizers, agricultural machinery and agricultural supplies.
Dalian Jingang Property Co., Ltd
Dalian Jingang Property Co., LTD., was founded in 1993 with more than 100 employees. The company provides high standard property services to the customer in accordance with the concept of serve customers with professional and high-quality property services and letting more customers experience the beauty of property services. At present, it covers an service area of more than 700,000 square meters, and heating area of nearly 500,000 square meters.
Dalian Jinwan Industrial Co., Ltd.
Jinwan industry has been developing Jinwan New Town for the first time since 2002, thus opening the road of its fine work. Project Jinwan New City and Jinwan Mountain City created a market with a total development area of over 1 million square meters, which was recognized by more than 20,000 owners.
Dalian Jinwan Construction Group Co., Ltd.
As a comprehensive large-scale private enterprise, Dalian Jinwan Construction Group Co., Ltd., is focusing on building construction projects, including municipal engineering, steel structure work, mechanized earthwork, decoration, mechanical and electrical installation, engineering equipment leasing, concrete manufacturing, construction labor services, Logistics and large retail malls.
Dalian Kaifei Chemical Co., Ltd.
In August 1993, Dalian Agrochemical Engineering Technology Research Center was established, jointly invested by Dalian Institute of Chemical Physics, Chinese Academy of Sciences and Dalian Jingang Group Co., Ltd.
Dalian Sumitomo Jingang Chemical Co., Ltd.
Established in 2009, Dalian Sumitomo Jingang Chemical Co., Ltd is a joint venture company invested by Dalian Jingang Group and Sumitomo Chemical Japan. It covers an area of 207700 square meters. The business scope is to develop, manufacture, process chemical intermediates (AFB) and new agricultural films. The company uphold a sense of mission and enthusiasm, pay close attention to safety, environment, quality. It focused on business development and committed to make contribution to society. For a more wonderful tomorrow.
Sinovac (Dalian) Vaccine Technology Co., LTD
Sinovac (Dalian) Vaccine Technology Co., LTD. (hereinafter referred to as "Dalian Sinovac") is a biotechnology high-tech enterprise jointly established by Sinovac Holdings (Hong Kong) Co., LTD and Dalian Kingport Group Co., LTD.
Daxiang Baopu Hotel
The core concept of the hotel is green, poetic, sincere, and love. It is an place of oriental aesthetics for sojourn, vegetarian, art, poetry, painting, Guqin, flower arrangements. It is a leading vegetarian eco-friendly hotel. It shows the enjoy of simply life and every little touches.
WRITE A MESSAGE TO US
Based on the corporate culture of "people-oriented", Jingang group is committed to moving closer to international group enterprises and promoting the steady and rapid development of group enterprises.